Mechanistic comparison of nn hexamethyleneamiloride and sr mefloquine based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
25%
Jaccard Similarity
18%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
nn and sr share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.250 means 25% of the combined target set is bound by both compounds. The IDF-weighted score of 0.175 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do nn and sr have in common?
nn and sr share 2 molecular targets with a Jaccard similarity of 25%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can nn and sr be combined?
nn and sr share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: nn or sr?
Both nn and sr have substantial PubMed research. View their individual profiles for full evidence scores.